Your session is about to expire
← Back to Search
NB Medication (on-going from acute treatment) for Obesity
Study Summary
This trial will test whether cognitive-behavioral therapy, when added to existing pharmacotherapy, helps people with binge eating disorder who are also obese.
- Obesity
- Binge Eating Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 & 3 trial • 31 Patients • NCT03063606Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
If a potential test subject is middle-aged, will they still be able to participate in this research?
"This trial is only open to adults aged 18-70. Out of the 963 active clinical trials, 252 are for patients under 18 and 718 are for people 65 and older."
What does NB Medication help patients with when they take it over an extended period of time?
"NB Medication (on-going from acute treatment) is not only useful in treating ADHD, but also seasonal affective disorder, smoking cessation, and smoke."
How can I participate in this research trial?
"Up to 38 individuals between 18 and 70 years old may be enrolled in this trial if they currently suffer from binge-eating disorder. Furthermore, it is imperative that potential patients also meet the following conditions: a recent history of treatment for both binge-eating disorder and obesity with no positive response, being available for the next 20 months, travelling ability to New Haven, Connecticut for weekly visits."
Are patients needed for this experiment currently?
"Although this particular trial is not looking for more participants, the clinicaltrial.gov website indicates that it was last updated on 7/27/2022 and was initially posted on 9/5/2017. There are 1161 other trials that are actively recruiting right now if you're interested in participating in medical research."
Share this study with friends
Copy Link
Messenger